tm
Seeing Is Believing
tm
Seeing Is Believing
Nabriva Therapeutics AG's activity chart (see below) currently has 20 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 69.44% with an average time for these price targets to be met of 523.67 days.
Most recent stock forecast was given by CARL BYRNES from NORTHLAND CAPITAL MARKETS on 06-Jan-2023. First documented stock forecast 13-Oct-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Mar-2022
$1
$0.6 (150.00%)
$450
3 years 9 months 2 days ago
(06-Jan-2023)
1/3 (33.33%)
$-0.3 (-23.08%)
207
$500
$499.6 (124900.00%)
$500
5 years 10 months 1 days ago
(07-Dec-2020)
0/4 (0%)
$405.5 (429.10%)
Hold Since 19-Mar-2020
$6
$5.6 (1400.00%)
$7
6 years 6 months 19 days ago
(19-Mar-2020)
2/2 (100%)
$-136.5 (-95.79%)
886
Hold Since 02-May-2019
$2
6 years 8 months 29 days ago
(09-Jan-2020)
2/2 (100%)
$-535.5 (-99.63%)
1333
Buy Since 18-Sep-2017
$10
$9.6 (2400.00%)
7 years 5 months 7 days ago
(01-May-2019)
1/1 (100%)
$-532.5 (-98.16%)
1072
What is NBRV (Nabriva Therapeutics AG) average time for price targets to be met?
Which analyst most recently updated their price target on NBRV (Nabriva Therapeutics AG)?
Which analyst has the most public recommendations on NBRV (Nabriva Therapeutics AG)?
Which analyst is the currently most bullish on NBRV (Nabriva Therapeutics AG)?
Which analyst is the currently most reserved on NBRV (Nabriva Therapeutics AG)?
